Sanger Sequencing Market Report 2026

Sanger Sequencing Market Overview

• Sanger Sequencing market size has reached to $3.29 billion in 2025 • Expected to grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.7% • Growth Driver: Genetic Illness Surge Fuels Sanger Sequencing Market Growth • Market Trend: Expansion Of Sanger Sequencing Services In Northern UK • North America was the largest region in 2025.

What Is Covered Under Sanger Sequencing Market?

Sanger sequencing, or chain termination sequencing, is a method for determining the nucleotide sequence of DNA. Sanger sequencing is used for smaller-scale initiatives and for validating the outcomes of deep sequencing, as it can create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels. The main types of sanger sequencing are shotgun sequencing, targeted gene sequencing, and others. Shotgun sequencing in Sanger sequencing refers to a method where random fragments of a long DNA molecule are sequenced in parallel and then assembled using their overlaps. The various laboratories include wet labs and dry labs. The various research includes in-house and outsourced. These are used in various applications such as diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others, and also by various end users such as academic, government research institutes, pharmaceutical companies, biotechnology companies, hospitals, and clinics.

What Is The Sanger Sequencing Market Growth Forecast?

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to ongoing need for confirmatory sequencing alongside NGS, growth in personalized medicine applications, rising demand for cost-effective targeted sequencing, expanding clinical diagnostics in emerging markets, increased collaborations between biotech firms and research institutes. Major trends in the forecast period include continued use of sanger sequencing for validation of NGS results, steady demand for targeted gene sequencing in diagnostics, growing application in biomarker and cancer research, increasing outsourcing of sequencing services to specialized labs, sustained adoption in forensics and reproductive health testing.

Global Sanger Sequencing Market Segmentation

1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing 2) By Laboratory: Wet Labs, Dry Labs 3) By Research: In-House, Outsourced 4) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications 5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics Subsegments: 1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing 2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing 3) By Other Sequencing: Nested PCR Sequencing, Capillary Electrophoresis Based Sanger Sequencing

What Is The Driver Of The Sanger Sequencing Market?

The rise in genetic illness is expected to propel the growth of the sanger sequencing market going forward. A genetic illness, or genetic disorder, is a medical condition caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is used to diagnose genetic illnesses by determining the exact order of nucleotides (the building blocks of DNA) in a specific gene or region of DNA. For instance, in August 2024, according to the National Health Service, a UK-based publicly funded healthcare system, approximately 2,300 individuals in the UK are living with thalassaemia as of 2024. Among them, around 800 have the severe form of the condition and depend on regular blood transfusions. Therefore, the rise in genetic illness is driving the growth of the sanger sequencing industry.

Key Players In The Global Sanger Sequencing Market

Major companies operating in the sanger sequencing market are Hoffmann La Roche, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific, Beckman Coulter, PerkinElmer Inc, LGC Limited, GenScript, Macrogen Inc, GENEWIZ Inc, Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd, SciGenom Labs Pvt Ltd, StarSEQ GmbH, GATC Biotech AG, Agilent Technologies, Azenta Life Sciences, CD Genomics, Novogene Sanger Services

Global Sanger Sequencing Market Trends and Insights

Major companies operating in the sanger sequencing market are focusing on expanding genomic laboratories to provide rapid sanger sequencing services to the North of the UK. Genomic laboratories are specialized facilities that conduct genetic testing and analysis to study the structure, function, and inheritance of genes and genomes, often for purposes such as diagnosis, research, and personalized medicine. For instance, in June 2023, Source Genomics, a UK-based company that offers genomic services, declared the extension of their genomic laboratory into the UK's north, which will boost the capacity of their Sanger sequencing services and speed up data delivery turnaround times. Expanding laboratory operations to the northern territories is a major advancement in providing equitable access to genomic services for research organizations nationwide. This geographical growth will allow customers across the country to benefit from top-quality Sanger sequencing services with quicker turnaround times.

What Are Latest Mergers And Acquisitions In The Sanger Sequencing Market?

In January 2023, Qiagen, a Germany-based provider of sample and assay technologies, acquired Verogen for $150 million. This acquisition allows QIAGEN to optimize its market-leading sample extraction and library prep automation capabilities, thereby enhancing both companies’ channel reach and presence to support the forensic market. Verogen is a US-based provider of sanger sequencing for human identification and forensic laboratories.

Regional Outlook

North America was the largest region in the sanger sequencing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sanger Sequencing Market?

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sanger Sequencing Market Report 2026?

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sanger sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.